EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

D-Dimer Trends Predict Recurrent Stroke in Patients with Cancer-Related Hypercoagulability

Jun Fujinami, Yoshinari Nagakane, Kei Fujikawa, Shohei Murata, Keiko Maezono, Tomoyuki Ohara, Toshiki Mizuno

Cerebrovascular Diseases Extra · 2023

DOI: 10.1159/000535644 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cerebrovascular Diseases Extra, 2023. Verfasst von Jun Fujinami und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Kyoto Second Red Cross Hospital, Kyoto, Japan, jun2473@gmail.com. Hauptthemen laut MEDLINE: Ischemic Stroke, Stroke, Thrombophilia, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In patients with cancer-associated hypercoagulability (CAH)-related stroke, D-dimer trends after anticoagulant therapy may offer a biomarker of treatment efficacy. The purpose of this study was to clarify the association between D-dimer trends and recurrent stroke after anticoagulant therapy in patients with CAH-related stroke.

Methods

We performed retrospective cohort study of consecutive patients with CAH-related stroke at two stroke centers from 2011 to 2020. The ratio of posttreatment to pretreatment D-dimer levels (post/pre ratio) was used as an indicator of D-dimer trends after anticoagulant therapy. Fine-Gray models were used to evaluate the association between post/pre ratio and recurrent stroke.

Results

Among 360 acute ischemic stroke patients with active cancer, 73 patients with CAH-related stroke were included in this study. Recurrent stroke occurred in 13 patients (18%) during a median follow-up time of 28 days (interquartile range, 11–65 days). Multivariate analysis revealed that high post/pre ratio was independently associated with recurrent stroke (per 0.1 increase: hazard ratio 2.20, 95% confidence interval 1.61–3.01, p = 0.012).

Conclusion

D-dimer levels after anticoagulant therapy were associated with recurrent stroke in CAH-related stroke patients. Patients with neutral trends in high D-dimer levels after anticoagulant therapy were at high risk of recurrent stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic StrokeStrokeThrombophiliaNeoplasmsHumansRetrospective StudiesRisk FactorsFibrin Fibrinogen Degradation ProductsCerebral InfarctionAnticoagulants

Stichwörter der Autor:innen

Cancer-related strokeD-dimerHypercoagulabilityTrousseau syndrome

Substanzen

fibrin fragment DFibrin Fibrinogen Degradation ProductsAnticoagulants

Autor:innen und Institutionen

  • Department of Neurology, Kyoto Second Red Cross Hospital, Kyoto, Japan, jun2473@gmail.com.
  • Department of Neurology, Kyoto Second Red Cross Hospital, Kyoto, Japan.
  • Department of Biostatistics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Department of Neurology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Zitieren

APA

Fujinami, J., Nagakane, Y., Fujikawa, K., Murata, S., Maezono, K., Ohara, T., & Mizuno, T. (2023). D-Dimer Trends Predict Recurrent Stroke in Patients with Cancer-Related Hypercoagulability. Cerebrovascular Diseases Extra. https://doi.org/10.1159/000535644

Vancouver

Fujinami J, Nagakane Y, Fujikawa K, Murata S, Maezono K, Ohara T, et al. D-Dimer Trends Predict Recurrent Stroke in Patients with Cancer-Related Hypercoagulability. Cerebrovascular Diseases Extra. 2023. doi:10.1159/000535644

BibTeX
@article{Fujinami2023,
  author = {Fujinami, Jun and Nagakane, Yoshinari and Fujikawa, Kei and Murata, Shohei and Maezono, Keiko and Ohara, Tomoyuki and Mizuno, Toshiki},
  title = {D-Dimer Trends Predict Recurrent Stroke in Patients with Cancer-Related Hypercoagulability},
  journal = {Cerebrovascular Diseases Extra},
  year = {2023},
  doi = {10.1159/000535644}
}
Kostenlos starten →